Loss or down‐regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts
- 3 November 2006
- journal article
- Published by Wiley in Cancer Science
- Vol. 98 (1) , 102-108
- https://doi.org/10.1111/j.1349-7006.2006.00356.x
Abstract
Loss or down-regulation of human leukocyte antigen (HLA) class I expression has been demonstrated in a variety of solid tumors. To date, such altered HLA expression has not been studied extensively in freshly isolated leukemic blasts. If it occurs, leukemic cells could escape T-cell surveillance as a consequence. Genotypes of nine leukemic cell lines were determined using a polymerase chain reaction for HLA classes I and II. Cells were also examined for HLA beta2-microglobulin, and allele-specific HLA protein expression using flow cytometry. Next, 44 samples of freshly isolated leukemic blasts from 43 patients with malignant hematological diseases were examined for allele-specific HLA expression using flow cytometry. Microsatellite analysis was performed to determine heterozygosity in the HLA region on chromosome 6. Genotype analysis for HLA class I together with microsatellite analysis demonstrated loss of HLA haplotype in HL-60 cells. No loss of HLA haplotype was observed in 44 samples of freshly isolated leukemic blasts. As reported previously, flow cytometric analysis rarely demonstrated loss or down-regulation of HLA expression at initial diagnosis (3/39; 7.7%); however, this was evident in two of five cases in relapse (40.0%), which contrasts with previous reports. In one patient with acute leukemia, HLA-A2 cell surface expression was present at initial diagnosis, lost at relapse, and completely restored after 48 h of culture in the presence of interferon-gamma. These results suggest loss of allele-specific HLA expression may be involved in the pathogenesis of relapse in patients with leukemia. The findings should be valuable in designing new strategies for clinical immunotherapy.This publication has 39 references indexed in Scilit:
- Tumor-Specific Cytotoxic T Lymphocyte Responses against Chondrosarcoma with HLA Haplotype Loss Restricted by the Remaining HLA Class I AlleleBiochemical and Biophysical Research Communications, 2001
- beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.Journal of Clinical Investigation, 1998
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell lineTissue Antigens, 1996
- Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Natural history of HLA expression during tumour developmentImmunology Today, 1993
- Loss of Human Leukocyte Antigen Expression on Colorectal Tumor Cell LinesJournal of Immunotherapy, 1993
- Polymerase-chain-reaction-based analysis of polymorphism in the HLA-B geneHuman Immunology, 1992
- Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporterNature, 1991